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Abstract
Background: Due to the wide application of engineered aluminum oxide nanoparticles and increased aluminum
containing particulate matter suspending in air, exposure of human to nano-scale aluminum oxide nanoparticles
(Al2O3 NPs) is becoming inevitable.
Methods: In the present study, RNA microarray coupled with metabolomics analysis were used to uncover
mechanisms underlying cellular responses to Al2O3 NPs and imply the potential rescue.
Results: We found that Al2O3 NPs significantly triggered down-regulation of mitochondria-related genes located
in complex I, IV and V, which were involved in oxidative phosphorylation and neural degeneration pathways, in
human bronchial epithelial (HBE) cells. Subsequent cell- and animal- based assays confirmed that Al2O3 NPs caused
mitochondria-dependent apoptosis and oxidative stress either in vitro or in vivo, which were consistent with the trends
of gene regulation. To rescue the Al2O3 NPs induced mitochondria dysfunction, disruption of small molecular metabolites
of HBE were profiled using metabolomics analysis, which facilitates identification of potential antagonizer or supplement
against nanoparticle-involved damages. Supplementation of an antioxidant, acetyl-L-carnitine, completely or
partially restored the Al2O3 NPs modulated gene expression levels in mitochondrial complex I, IV and V. It further
reduced apoptosis and oxidative damages in both Al2O3 NPs treated HBE cells and animal lung tissues.
Conclusion: Thus, our results demonstrate the potential mechanism of respiratory system damages induced by
Al2O3 NPs. Meanwhile, based on the metabolomics profiling, application of acetyl-L-carnitine is suggested to
ameliorate mitochondria dysfunction associated with Al2O3 NPs.
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Background
Nano-scale aluminum oxide (Al2O3) particles are widely
used in insulator layers, powder coating, and fluorescent
lamp material. Meanwhile, aluminum (Al) is a common
metal component in ultrafine airborne particles (PM2.5)
in the ambient environment1,2 and is relatively stable in
the form of aluminum oxide. These ultrafine aluminum
particles have different physical, chemical, and biological
characteristics, and are likely to be more toxic than the
same conventional sized materials [1]. Thus, increased
and inevitable occupational and environmental expo-
sures to ultrafine Al2O3 particles are considered as a
health risk, while, prevention or intervention measures
have not been investigated. Generally, ultrafine particles
can be inhaled more deeply than large particles, leaving
sediment on the surface of the trachea, bronchus, and al-
veoli. Lung tissue is considered the primary target organ
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for inhaled ultrafine particles. Accordingly, aluminum
oxide nanoparticles (Al2O3 NPs) were employed as an
ultrafine particle model to explore the impacts of
aluminum ultrafine particles on the respiratory system.
Apoptosis is an endpoint to assess toxicity of metal
oxide nanomaterial, providing a benchmark against
which to evaluate the potential toxicity of engineered
nanoparticles [2–4]. There are two major apoptotic
pathways initiated by either mitochondria or cell surface
receptors [5]. Mitochondria-mediated apoptosis is also
called the ‘intrinsic’ pathway and occurs in response to a
wide range of death stimuli, and is characterized by cas-
cade reactions including mitochondrial outer membrane
permeabilization (MOMP), release of cytochrome c into
the cytoplasm to activate caspase-9 and subsequent
caspase-3 [5, 6]. The intrinsic pathway is involved in im-
mune disorders [7], neurodegeneration [8] and cancer
[9, 10]. Studies investigating ambient particulate matter
or nanoparticles suggest apoptosis or mitochondrial dys-
function are sufficient end-points to monitor toxicity
[11–13], but conventional toxicity assays may not suffice
to fully understand the cellular responses of ultrafine
particle exposure. Thus, a more comprehensive ap-
proach to determining how cells respond to ultrafine
particles is required.
“Omics” analysis, including transcriptomics, proteomics,
and metabolomics, coupled with appropriate computa-
tional approaches to determine statistically significant
gene, protein, metabolite or pathway regulation can be
used as a tool to identify the potential hazards and mecha-
nisms of nanoparticle toxicology [14–16]. These newly de-
veloped high-throughput approaches have been used to
study the impact of nanomaterials, including metal and
metal oxide nanoparticles [17–19]. In such studies, the
“omics” technologies are used to predict interaction
between nanoparticles and biological systems, facilitate
assessment of systemic toxicity due to nanomaterials,
reveal potential strategies for risk mitigation.
Metabolomics analysis is one of the most applied
“omics” analysis that facilitates understanding of the
modulation of small molecules following exposure.
Acetyl-L-carnitine (ALCAR), an antioxidant dietary sup-
plement, could be detected through GC/TOF/MS analysis
and plays a vital role in oxidation of fatty acid metabolic
pathways. It is a constituent of the inner mitochondrial
membrane and has many fundamental functions, includ-
ing acetyl CoA uptake [20], improving mitochondrial
bioenergetics [21] and prevention of mitochondrial en-
zyme oxidation [22]. The acetyl group of ALCAR is used
to produce the antioxidant glutathione (GSH), reducing
oxidative stress, and protecting cells against lipid peroxi-
dation [23, 24]. ALCAR also contributes to the bioener-
getics processes, therefore, it plays a vital role in
mitochondrial-related disorders [25, 26].
Here, we used human bronchial epithelia (HBE) as a
model system due to their importance in defense against
inhaled pathogens and particulates [27]. We investigated
changes in gene expression profiles and small molecular
metabolites in HBE cells induced by Al2O3 NPs. Gene
Ontology (GO) and the Kyoto Encyclopedia of Genes
and Genomes (KEGG) were used to evaluate pathways.
We showed that Al2O3 NPs are capable of triggering spe-
cific changes in HBE cell gene expression, specifically in
mitochondria associated genes. We assessed mitochondria-
mediated apoptosis in the presence or absence of acetyl-L-
carnitine as a supplement to oppose mitochondrial
dysfunction caused by Al2O3 NPs. The pathological alter-
ations and ALCAR rescue were observed in mouse lung
tissues treated with Al2O3 NPs. Our results suggests Al2O3
NPs cause toxicity and mitochondrial dysfunction that may
be remedied by acetyl-L-carnitine treatment.
Results
Overview of mRNA microarray profiles
To determine how gene transcription was altered due to
Al2O3 NP exposure, HBE cell mRNA profiling was eval-
uated by RNA microarray. As shown in Fig. 1a, Al2O3
nanoparticles exerted specific transcriptional effects
leading to significantly increased expression of 54 genes
and decreased expression of 304 genes, with a cutoff as
2 or more fold change and P < 0.05. GO enrichment
classifies transcriptional changes observed between con-
trol and treatment groups. Notably, the GO analysis re-
vealed that genes encoding proteins necessary for
mitochondrial function were differentially expressed.
Significantly, of the genes differentially regulated, 23/
154 genes involved in cell components (CC) (Fig. 1b);
11/85 genes involved in molecular function (MF)
(Fig. 1c), and 14/183 in biological process (Fig. 1d).
These mitochondria involved enrichment were labeled
with red color in Fig. 1. Therefore, a total of 27 mito-
chondrial related genes were identified, the fold change,
P value and functions of their encoded proteins are
shown in Table 1.
Subsequently, these 27 genes were subjected to KEGG
pathway enrichment analysis. These selected genes were
annotated with the KEGG pathway database and hypergeo-
metric tests were used to estimate the significance of
enrichment. Among these pathways, mitochondrial func-
tion and neural system disease were significantly enriched
(Fig. 2a). Figure 2b is schematic oxidative phosphorylation
pathway by KEGG. Our microarray data suggested that
NADH ubiquinone oxidoreductase-encoding genes (ND
UFA2 and NDUFS4), NADH dehydrogenase-encoding
genes located in mitochondrial complex 1 (NDUFC2,
NDUFA1, and NDUFA4), NADH ubiquinol-cytochrome c
reductase gene UQCR11 (complex III), cytochrome c oxi-
dase genes (COX7B and COX17 (complex IV)), and the
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mitochondrial ATP synthase gene ATP5H (complex V, F0
unit) were among the most affected genes. The down-
regulated genes were noted with blue color and the up-
regulated gene was noted with red color in Fig. 2b.
Levels of mRNA expression were confirmed by qRT-PCR
To validate our RNA microarray data, we performed qRT-
PCR to validate 11 differentially expressed mitochondrial
genes that involved in at least two enrichments in GO cat-
egories. In HBE cells and lung tissue obtained from mice
treated with Al2O3 NPs, UQCR11 was upregulated and
NDUFA4, NDUFA2, NDUFS4, COX7B, NDUFC2, ND
UFA1, ATP5H, COX17, DLST, and CS were downregu-
lated in a dose-dependent manner (Fig. 3a and b). With
the exception of NDUFA4, which was down-regulated by
qRT-PCR analysis, the trend in mRNA regulation of the
other 10 genes was consistent between microarray and
qRT-PCR (Fig. 3c).
Apoptosis is induced in HBE cells and lung tissue
following Al2O3 NPs exposure
Cytotoxicity of Al2O3 NPs was evaluated by CCK-8
assay. HBE cells were exposed to Al2O3 NPs at different
doses (12.5-1000 μg/ml) every 24 h up to 7 days.
100 μg/ml or higher doses showed significant toxicity to
HBE cells 24 h after treatment (Fig. 4a). To further verify
that Al2O3 NP exposure caused apoptosis, cells was
assessed by flow cytometric analysis of annexin V-FITC
and PI double staining. After 12 h treatment, significant
enhancement of apoptosis (2.24 ± 0.17 %) was observed
only in 500 μg/mL Al2O3 NPs HBE cells (Additional file 1:
Figure S1A). Further, apoptosis occurred 8.98 ± 0.39 %
and 16.77 ± 0.57 % in HBE cells treated with 100 or
Fig. 1 An overview of RNA microarray profiles. a Volcano diagram depicting the differentially expressed genes identified by a linear model of
limma Software Package. Each red point corresponds to one differentially expressed gene. Heat map of samples based on the RNA microarray
gene expression profiles. The down-regulation and up-regulation of genes were expressed by green color and red color correspondingly.
b sub-ontology cellular component (CC) of gene ontology enrichment c) the sub-ontology molecular function (MF) shows mitochondria are the
mostly involved enrichment categories. d sub-ontology of biological process (BP). The mitochondria-invovled GO enrichments were labeled with red
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500 μg/mL Al2O3 NPs for 24 h, respectively, but signifi-
cant increase of cellular necrosis was not observed at
either treatment concentrations (Fig. 4b). To determine
pathways induced by Al2O3 NP exposure, caspase-3, 8,
and -9 activities were evaluated. Increased activities of
caspase-3 and -9 were shown in Al2O3 NPs treated
groups, suggesting HBE cell apoptosis is initiated by the
intrinsic pathway (Fig. 4c). Similar results were obtained
from lung tissues harvested from mice treated with Al2O3
NPs (Fig. 4c).
H&E and TUNEL staining was performed to detect path-
ology and programmed cell death in situ. Inflammation
and red blood cell located in pulmonary mesenchyme were
observed in both low and high dose exposed mice lung tis-
sue. The typical pathological alterations were showed in
Fig. 5. Figure 5a showed a normal structure of lung tissue.
As shown in Fig. 5b, pneumorrhagia characterized by inter-
stitial red blood cells distribution was seen in lung tissue
obtained from mice treated with low dose Al2O3 NPs.
Massive lymphocytes infiltration, especially the subpleural
area, were observed in high dose Al2O3 NPs treated mice
lung tissue (Fig. 5c). The pathological lesions scores were
showed in Fig. 5g. Compared with control group, the
pathological lesion score increased significantly in both
nanoparticle treated lung tissues (P < 0.05), However, high
dose exposure did not enhance the pathological lesions in
lung tissue significantly when compared with low Al2O3
NPs treatment. For both treatment groups, pathological
scores suggested mild to moderate alveolitis in lung tissues
of mice, further, following ALCAR rescue, the alveolitis
were attenuated to mild degree. ALCAR ameliorated the
damages against Al2O3 NPs significantly (P < 0.05), com-
pared with corresponding Al2O3 NPs treated groups.
TUNEL-positive cells were not observed in the
bronchial epithelia in untreated mice lung (Fig. 5d).
Treatment with 10 mg/m3 Al2O3 NPs resulted in de-
generation of lung cells and the massive bronchial
epithelial cells had significant apoptosis (Fig. 5e)
Ameliorated apoptosis was observed in bronchial epi-
thelia of mice exposed to high dose Al2O3 NPs fol-
lowing ALCAR rescue (Fig. 5f ). The proportion of
TUNEL-positive bronchial epithelia were showed in
Fig. 5h. For both low and high dose Al2O3 NPs treat-
ment, ALCAR could partially rescue apoptosis of
bronchial epithelia to control level.
Dysfunction of mitochondria induced by Al2O3 NPs
The mitochondria-mediated apoptosis pathway is char-
acterized by destruction of mitochondrial membrane po-
tential and subsequent release of cytochrome c into the
cytoplasm [6], accompanied by decreased ATP synthesis.
The fluorescent probe JC-1 staining showed red fluores-
cence in normal cells, indicating intact mitochondrial
membrane potential, while cells treated with 100 and
500 μg/ml Al2O3 NPs were stained green after 12 or
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24 h treatment, indicating clear damage to the mito-
chondrial membrane potential as shown in Additional
file 1: Figure S1B and Fig. 6a. Additionally, cytoplasmic
cytochrome c significantly increased in cells treated with
Al2O3 NPs (Fig. 6b), however, this was lower than the
positive control (CCCP).
ATP levels were detected by luminometer after 24 h
exposure. In both HBE cells and lung tissues from mice
treated with Al2O3 NP, ATP decreased compared to the
control (Fig. 6b). Collectively, our results suggest Al2O3
NPs exposure is cytotoxic.
Al2O3 NPs induce oxidative stress in both HBE cells and
mice lung tissues
To assess the importance of oxidative stress in Al2O3
NP cytotoxicity, ROS, H2O2, O2
.- and MDA levels were
evaluated in HBE cells 12 or 24 h after treatment. Cor-
respondingly, ROS and MDA levels were evaluated in
mice lung tissues. ROS generation is a main cause of
mitochondria-dependent apoptosis. We used DCFH-DA
as a reporter of ROS generation, and as shown in Fig. 7a,
level of ROS increased in cells treated with Al2O3 NPs
for 24 h, indicated by higher intensity of fluorescence.
Fig. 2 KEGG pathway enrichment analysis of mitochondria related genes. a A total of 27 mitochondria related genes were analyzed through DAVID
functional annotation cluster tool. These genes mainly are involved in five KEGG pathways. Oxidative phosphorylation is the most significant enrichment.
b A schematic figure of the oxidative phosphorylation pathway by KEGG. mRNA microarray assay predicted up-regulated genes are stainded red, and
down-regulated genes are stained blue in this schematic figure
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Fig. 3 (See legend on next page.)
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As shown in Additional file 1: Figure S1C and Fig. 7b,
Al2O3 NP treatment significantly increased ROS and O2
.-
levels, but not H2O2 levels, in HBE cells. Comparable re-
sults were observed in lungs obtained from mice treated
with Al2O3 NPs. Similarly, MDA, the end product of lipid
peroxidation, also increased as shown in Fig. 7b and
Additional file 1: Figure S1C. For all of these oxidative
stress-involved assays, the positive control (CCCP) dem-
onstrated stronger stimulus to HBE cells than Al2O3 NPs.
Metabolic analysis showed up- and down- regulated
metabolites of HBE cells
According to PCA analysis, significant differences were
observed between control HBE cells and HBE cells
treated with either 100 μg/ml or 500 μg/ml Al2O3 NPs
(Additional file 1: Figure S2). We used MetaboAnalyst to
identify key metabolism alterations between untreated
and treated HBE cells. After Bonferroni correction (p
cut-off < 0.00001), we found 9 down-regulated and 11
up-regulated small molecules in treated samples in a
dose-dependent manner (Table 2). Among differentially
regulated metabolites, acetyl-L-carnitine (ALCAR) (p =
3.64E−09), 4-Methoxyphenylacetic acid (p = 7.61E−07) and
thymine (p = 2.99E−07) were the lowest in P value. Because
ALCAR is important for mitochondrial function, it could
be a candidate supplement to rescue the adverse effects of
Al2O3 NPs on HBE cells.
Protective effects of ALCAR to HBE cells against Al2O3
NPs induced mitochondria dysfunction and oxidative
stress
To test whether ALCAR could reduce cell toxicity due
to Al2O3 NPs, toxicity was evaluated in cells treated with
0.1 or 0.3 mg/ml ALCAR at treatment with 500 μg/ml
Al2O3 NPs. As shown in Fig. 8a, 0.3 mg/ml ALCAR
treatment significantly reduced the cell viability loss in
both 100 and 500 μg/ml Al2O3 NP treated cells, and was
used as a therapeutic dose for the remaining experi-
ments. Compared to untreated cells and lungs, co-
treatment with ALCAR attenuated caspase-3 and -9
activities as shown in Fig. 8b. Caspase-8 activity was not
affected by ALCAR treatment (Fig. 8b). To confirm
ALCAR treatment reduced apoptosis, treated cells were
evaluated by annexin-V and PI staining. Similarly,
0.3 mg/ml ALCAR treatment reduced annexin-V stain-
ing significantly (Fig. 8c). ALCAR treatment also re-
duced production of intracellular ROS, O2
.- and MDA in
HBE cells and lungs harvested from mice treated with
Al2O3 NPs as shown in Fig. 9a and b. ALCAR could only
partially rescue HBE cells against CCCP induced oxida-
tive stress (Fig. 9a). ALCAR also demonstrated protect-
ive effects to mice bronchia epithelia from apoptosis
(Fig. 5f ).
Gene expression levels in HBE cells and mouse lung
tissues after ALCAR treatment were evaluated by qRT-
PCR. Altered expression of genes located in mitochon-
dria complex IV and V, COX7B, COX17 and ATP5H,
was comparable to control cells following ALCAR treat-
ment. Expression of genes in complex I, including
NDUFA1, NDUFA2, NDUFA4, NDUFC2 and NDUFS4
were partially normalized following ALCAR treatment.
UQCR11, DLST, and CS expression was unresponsive to
ALCAR treatment (Fig. 10).
Discussion
Using high-throughput mRNA sequencing and compu-
tational approaches, we showed that Al2O3 NPs cause
changes in gene expression in HBE cells. Among the dif-
ferentially expressed genes, mitochondrial genes were
among the most significantly affected category. Further,
cell and animal based functional assays confirmed that
Al2O3 NPs caused mitochondrial dysfunction and oxida-
tive stress in HBE cells and mouse lung tissue. Metabo-
lomics analysis showed downregulation of ALCAR in
HBE lysate in a dose-dependent manner following Al2O3
NP treatments. Co-treatment of cells with ALCAR and
Al2O3 NPs prevented mitochondrial dysfunction both in
vivo and in vitro.
Inhalation is one of the major exposure routes for
nano-scale materials, including engineered nanoparticles
and ambient particulate matter (PM), which have effects
on the respiratory system [28]. Various nanoparticles are
reported to produce pulmonary lesions. For example, re-
spiratory administration of single-walled carbon nano-
tubes (SWCNTs) increased collagen and alveolar wall
thickness [29]. Well dispersed nickel-oxide nanoparticles
increase inflammation and cytotoxicity in C57BL/6 J
mice lung tissues [30]. Transcriptomic and proteomic
approaches implicate that inflammation and oxidative
stress are involved in pulmonary toxicity caused by silica
nanoparticles [31]. Chronic exposure to ambient PM can
cause lung remodeling, with particle deposition on ter-
minal bronchioles and first-generation respiratory bron-
chioles [32]. Though aluminum is considered as a neural
toxin, lung tissue could be the primary organ affected by
inhaled nano-scale Al2O3 particles from either
(See figure on previous page.)
Fig. 3 qRT-PCR validation of the expression levels of modulated mitochondria-related mRNA. a Mitochondria-related gene expression level in HBE
cells treated with 50, 100, 250 or 500 μg/ml Al2O3 NPs. Gene expression is regulated in a dose-dependent manner b: Gene expression level of
lung tissues in mice exposed to Al2O3 NPs through inhalation. Gene expression is regulated in a dose-dependent manner. c Except NDUFA4, fold
change of modulated genes in cells treated with 100 μg/ml Al2O3 NPs are consistent with array data
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Fig. 4 Cell viability and apoptosis of HBE cells after exposure to Al2O3 NPs. a Cell viability of HBE cells were analyzed through CCK-8 assays after
exposure to Al2O3 NPs. b Apoptosis induction was significantly enhanced by Al2O3 NP exposure, and the proportion of necrosis was not significantly
modulated c) Assessments of caspase-3, -8, and -9 activities in HBE cells and lung tissues harvested from mice treated with Al2O3 NPs. The increase of
caspase-9 and -3 suggested that Al2O3 NPs induced apoptosis in HBE are mitochondria involved.
*P < 0.05, compared with untreated control
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engineered or ambient sources. According to the Chinese
Health standard for dusts of aluminum, aluminum oxide,
and aluminum alloys in the air of workplace (GB11726-
89), the maximum allowable concentration for Al2O3
powder in air is 6 mg/m3. Among these suspended parti-
cles, the health effects of nano-scaled Al2O3 particles
should be intensively considered due to its longer suspen-
sion and lower deposition in respiratory system than other
large particles. In the present study, the exposure doses of
Al2O3 NPs to mice were set to 2 or 10 mg/m
3 to evaluate
the potential pulmonary damages.
Mitochondrial function was used as an indicator to
evaluate the biological effects of various nanomaterials
[33]. Copper oxide nanoparticles induce apoptosis in
human hepato-carcinoma (HEPG2) cells through the
intrinsic apoptosis pathway, which is accompanied by
increased reactive oxygen species generation and oxida-
tive stress and the collapse of mitochondria membrane
Fig. 5 HE and TUNEL staining of lung tissues harvested from mice exposed to Al2O3 NPs. a HE staining of control mice lung tissue b) arrows
showed pneumorrhagia in lung tissue from 2 mg/m3 Al2O3 NP exposure c) arrows demonstrated lymphocytes infiltration of lung tissue due to
exposure to 10 mg/m3 Al2O3 NPs d) few apoptosis cells were observed in control mice lung tissue by TUNEL staining e) massive apoptosis in
bronchial epithelia were induced by 10 mg/m3 Al2O3 NP exposure as shown by arrows f) ALCAR supplement reduced apoptosis of bronchial
epithelia in 10 mg/m3 Al2O3 NP exposed mice lung tissue. The arrows show apoptotic epithelial cells. g The pathological lesion score of mice
lung tissues h) Proportion of TUNEL-positive bronchial epithelia within each group. *P < 0.05, compared with untreated control. #P < 0.05, compared
with corresponding control
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potential [34]. Nymark et al [33] combined transcrip-
tome and microRNA analysis to identify mitochondrial
dysfunctions induced by multi-walled carbon nanotubes
and 26 genes with known mitochondrial function were
identified. Additionally, GO analysis showed that the
most significantly enriched biological process among the
26 differentially expressed genes was gluconeogenesis.
Our studies suggest mRNA profiling analysis is a reason-
able strategy to study the Al2O3 NP toxicity on HBE
cells. A total of 27 genes associated with the mitochon-
dria correlated to Al2O3 NP treatment. In contrast to
Nymark’s results, our array data suggested that oxidative
phosphorylation was the most significantly affected bio-
logical process in treated cells. Gene expression levels
were confirmed by qRT-PCR in HBE cells and mouse
lung tissues exposed to Al2O3 NPs, further implicating
altered mitochondrial function.
Mitochondria-mediated apoptosis is initiated by mito-
chondrial outer membrane permeabilization and release
of cytochrome c into the cytoplasm [6]. Cytochrome c
binds to apoptosis protease activating factor-1 (Apaf-1),
which leads to activation of caspase-9 and -3, and is es-
sential for DNA damage and apoptosis [35]. To deter-
mine whether differential expression of mitochondrial
genes may lead to apoptosis, we monitored cell viability
and mitochondrial function in cells and tissues exposed
to Al2O3 NPs. Decreased mitochondrial membrane
potential, increased caspase-9 and -3, and increased
Fig. 6 Mitochondrial dysfunction is observed in both HBE cells and in lung tissues treated with Al2O3 NPs. a JC-1 staining showed alteration of
mitochondrial membrane potential. The left panel shows cells from control group indicating that only red fluorescence was observed. After treatment
with 100 or 500 μg/ml Al2O3 NPs, increased green fluorescence and decreased red fluorescence were observed, which suggested collapse
of mitochondrial membrane potential. CCCP was employed as positive control and demonstrated strong damages to mitochondrial membrane potential
b) Cytochrome c is released from mitochondria, therefore, cytosol cytochrome c concentration was enhanced in HBE cells. Meanwhile
ATP synthesis decreased in both HBE cells and lung tissues exposed to Al2O3 NPs.
*P < 0.05, compared with untreated control, #P < 0.05,
compared with positive control (CCCP)
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apoptosis were observed in cells and lung tissues ex-
posed to Al2O3 NPs, suggesting Al2O3 NPs causes cyto-
toxic effects in the pulmonary tract.
Mitochondria are the primary source of cellular ROS,
produced through oxidative phosphorylation, especially
at levels of complexes I and III of the respiratory chain
[36]. Excessive ROS production can lead to mitochon-
drial oxidative damage, which can lead to cell apoptosis.
O2
.- is an indicator of mitochondrial ROS production,
and is generated by the addition of one electron to O2.
Most intracellular ROS are derived from superoxide O2
.-
and elicit various pathological events, including DNA
damage and apoptosis [37–39]. Due to the small size
and large surface area of nanoparticles, ROS are usually
produced when cells are exposed to nanoparticles. As a
result, oxidative stress and lipid peroxidation have been
hypothesized to play an important role in nanoparticle
toxicity [34, 40]. In the present study, alteration of mito-
chondrial membrane potential, ROS and lipid peroxida-
tion were significantly higher in HBE cells exposed to
Al2O3 NPs after 12 or 24 h treatment, while prominent
enhancement of apoptosis and gene modulation were ob-
served 24 h after treatment. Therefore, the mitochondria-
involved dysfunction could account for Al2O3 NPs
induced gene modulations and subsequent apoptosis.
Significantly, the antioxidant ALCAR reduced cell
apoptosis effectively, suggesting that mitochondria as-
sociated oxidative stress is involved in Al2O3 NP
cytotoxicity.
The carnitine: acylcarnitine translocase (CACTL) lo-
cated in the mitochondrial inner membrane facilitates
cytosolic ALCAR entry into the mitochondria [41].
Fig. 7 Oxidative stress and lipid peroxidation induced by Al2O3 NP exposure. a ROS is induced by Al2O3 NP exposure in HBE cells with increased
green fluorescence. CCCP was employed as positive control. b ROS, O2
.- and lipid peroxidation production MDA are increased in HBE cells and
mouse lungs following Al2O3 NP exposure. The H2O2 level is not affected by Al2O3 NPs exposure in HBE cells.
*P < 0.05, compared with untreated
control, #P < 0.05, compared with positive control (CCCP)
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Inside the mitochondrial matrix, carnitine palmityltransfer-
ase II releases carnitine from ALCAR. Carnitine is then
transported back across the membrane by carnitine-
acylcarnitine translocase [42]. Therefore, ALCAR is consid-
ered a specific intramitochondrial acetyl-donor and may be
involved in restoring mitochondrial function [43]. ALCAR
and its derivative L-carnitine supplementation have wide
clinical applications to restore neurologic disorders [44] or
improve liver function [42]. Our studies using metabolo-
mics suggest ALCAR levels decrease dramatically due to
Al2O3 NP exposure. Because ALCAR is reported to im-
prove mitochondrial function and restore mitochondrial
gene expression, [45] we supplemented HBE cells and mice
with ALCAR during exposure to Al2O3 NPs. ALCAR treat-
ment significantly increased cell viability and decreased
apoptosis, corresponding to decreased caspase activity and
cytochrome c release. Additionally, ALCAR reduced oxida-
tive stress and lipid peroxidation due to Al2O3 NP expos-
ure. ALCAR supplementation fully or partially rescued
altered gene expression of mitochondrial-associated pro-
teins due to Al2O3 NP exposure. Consistent with our stud-
ies, treating rats with ALCAR rescued the function of
complexes I, IV and V in brain mitochondria [46]. ALCAR
additionally reduced ROS production and ATP depletion
in an in vitro cell model [26]. We observed that ALCAR
could partially restore oxidative stress and lipid peroxida-
tion induced by a powerful mitochondrial uncoupling
agent CCCP, therefore demonstrating strong anti-oxidative
activities in the present study.
NADH dehydrogenase (complex I) and cytochrome c
oxidase (complex IV) are highly susceptible to oxidative
damage [47, 48]. Our data indicate that genes involved
in complex I, IV, and V were significantly down-
regulated in both Al2O3 NP-treated HBE cells and in
lung tissues harvested from mice exposed to Al2O3
NPs, suggesting that loss of mitochondrial function
may be due to compromised NADH-linked respiration
and complex I-driven electron transport. Furthermore,
our data suggests that ALCAR may be useful in main-
taining ATP levels under specific pathologic conditions
[21]. ALCAR can partially restore the gene expression
level in complex I and completely restore gene expres-
sion level in complex IV and V, consistent with previ-
ous reports that ALCAR protects key mitochondrial
enzymes (complex I and IV) from oxidative damage.
In the present study, ALCAR rescued HBE cells
against Al2O3 NPs induced apoptosis, which is attributed
to the anti-oxidative activities and gene restoration. Fur-
ther, ALCAR could be a specific supplement according
to our metabolomics assays because it was the most sig-
nificantly down-regulated small molecule metabolite fol-
lowing Al2O3 NPs exposure. However, studies on the
involved metabolic pathways and underlying mecha-
nisms are further required.
Table 2 Metabolomics analysis of Al2O3 NPs exposed HBE cell lysates
Peak Metabolic pathway HMDB Regulation
3-Phenylbutyric Acid Taurine and Hypotaurine Metabolism HMDB01955 down
Melatonin Tryptophan Metabolism HMDB01389 down
cis-Aconitic acid Citric Acid Cycle HMDB00072 down
3-Methylhistidine Histidine Metabolism HMDB00479 down
Acetyl-L-carnitine Beta Oxidation of Very Long Chain Fatty Acids HMDB00201 down
4-Methoxyphenylacetic acid Tyrosine Metabolism HMDB02072 down
N-Acetyl-L-methionine Betaine Metabolism HMDB11745 down
N-Formyl-L-methionine Betaine Metabolism HMDB01015 down
Pyridoxal 5′-phosphate Vitamin B6 Metabolism HMDB01491 down
L-Serine Homocysteine Degradation HMDB00187 up
Adenine Phytanic Acid Peroxisomal Oxidation HMDB00034 up
Succinic acid Aspartate Metabolism HMDB00254 up
D-Glutamic acid Glutamate Metabolism HMDB03339 up
Thymine Pyrimidine Metabolism HMDB00262 up
Ethylmalonic acid Mefanamic Acid Pathway HMDB00622 up
Ureidopropionic acid Beta-Alanine Metabolism HMDB00026 up
(-)Matairesinol Phenylacetate Metabolism HMDB35698 up
Taurocholic Acid Bile Acid Biosynthesis HMDB00036 up
Docosahexaenoic acid Mefanamic Acid Pathway HMDB02183 up
Pyridoxine Vitamin B6 Metabolism HMDB00239 up
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Fig. 8 (See legend on next page.)
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Conclusions
In summary, we present a approach based on tran-
scriptomics coupled with metabolomics methods, to re-
veal key genes involved in response to engineered Al2O3
NPs. These nano-scale Al2O3 particles are abundant in
either occupational environments or as components of
particulate matters in the ambient environment. RNA
microarray revealed that down-regulated genes were
mainly associated with mitochondrial complexes I and
IV and oxidative stress. Treatment with the antioxidant
ALCAR which is screened according to the metabolo-
mics analysis was tested in our metabolomics study, and
restored mitochondrial function through both in vivo
and in vitro studies. We suggest that our “omics”
(See figure on previous page.)
Fig. 8 The ameliorative effects of ALCAR supplementation against cell viability lost and apoptosis. a 0.3 mg/ml ALCAR co-treatment effectively
increased cell viability. b 0.3 mg/ml ALCAR co-treatment with Al2O3 NPs ameliorated activities of caspase-3 and -9 completely or partially to control
level in HBE cells by c) 0.3 mg/ml ALCAR co-treatment partially protected HBE cells from apoptosis induced by Al2O3 NPs.
*P < 0.05, compared with
untreated control, #P < 0.05, compared with corresponding control within each treatment group
Fig. 9 Oxidative stress and lipid peroxidation are reduced after ALCAR rescue. a Oxidative stress and lipid peroxidation are reduced by ALCAR
supplementation in HBE cells and b) lung tissues from mice treated with Al2O3 NPs.
*P < 0.05, compared with untreated control, #P < 0.05,
compared with corresponding control within each treatment group
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technologies can be used to identify specific pathways
involved in toxicities due to Al2O3 NPs and provides
insight into identifying potential treatment solutions.
Our study is the first to demonstrate the use of ALCAR
to restore mitochondrial function and protect cell tox-
icity from Al2O3 NP exposure in vivo and in vitro.
Fig. 10 Gene expression levels after ALCAR rescue. a Expression levels of genes located in complex I, IV and V are partially or completely normalized
after ALCAR rescue in HBE cells and in b) lung tissues from mice exposed to Al2O3 NPs
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Methods
Nanomaterials and animals
Al2O3 NPs were purchased from Plasmachem GmbH,
Germany (>99.8 % purity). The particle size and zeta po-
tential of Al2O3 NPs in PBS suspension was 64.17 nm
and 37.1 mV, which was analyzed by a zetasizer (nano-
zs90, Malvern Instruments, UK) (Additional file 1:
Figure S3).
Thirty-six male and 36 female ICR mice (20–22 g)
were purchased from Shanghai SLRC Laboratory Animal
Co. Ltd., China.
Cell culture and RNA extraction
The human bronchial epithelial cell line (HBE) (American
Type Culture Collection) was maintained in Dulbecco’s
modified Eagle’s medium (DMEM) at 37 °C in 5 % CO2.
The culture medium was supplemented with 10 % (v/v)
fetal bovine serum (FBS), penicillin (100 U/ml), and
streptomycin (100 μg/ml). Cells were seeded in 10 cm cul-
ture dishes and exposed to 100 μg/ml Al2O3 NPs with
three biological replicates. At 24 h post treatment,
complete medium was removed and adherent cells were
collected. Total RNA was extracted using the TRIZOL re-
agent (Invitrogen, U.S.) according to the manufacturer’s
instructions.
RNA microarray and gene expression analysis
An Agilent Array platform (Agilent Technologies, Santa
Clara, CA, USA) was employed for microarray analysis.
The labeled cRNAs were hybridized onto a Human
LncRNA Array v3.0 (8 × 60 K; arraystar) chip designed
for 26 109 coding genes. The arrays were scanned using
an Agilent G2505C scanner and the fluorescence inten-
sity was analyzed with Agilent Feature Extraction soft-
ware (version 11.0.1.1). Quantile normalization and
subsequent data processing were performed using the
GeneSpring Gx v12.0 software package (Agilent Tech-
nologies). An absolute fold change of 2 or more and
0.05 adjusted P-value were set as cutoff to evaluate the
significance of gene expression differences of raw data.
Functional group analysis
DAVID 6.7 (Database for Annotation, Visualization, and
Integrated Discovery), a functional annotation tool,
was used to analyze differentially expressed genes.
The DAVID functional annotation cluster tool pro-
vides three structured networks of defined terms that
describe the attributes of gene products. The P-value
was set to 0.1 to denote the significance of GO en-
richment in the differentially expressed mRNA list.
Fold enrichment (-lg (P-value)) was used to denote
the enrichment of a particular GO term. Pathway
analysis for differentially expressed mRNAs was
performed on the KEGG database. This analysis
determines the biological pathways for which a sig-
nificant enrichment of differentially expressed mRNAs
exist (P-value was set as 0.05).
Metabolomics analysis of Al2O3 NPs treated HBE cells
GC/TOFMS analysis was performed using an Agilent
7890 gas chromatography system coupled with a Pegasus
4D time-of-flight mass spectrometer. HBE cells were ex-
posed to Al2O3 NPs (0, 100, and 500 μg/ml) for 24 h
with 9 biological replicates. Then the cell lysate sample
were prepared and analyzed as described [16].
Animal treatment
Mice were maintained and used according to the guide-
lines of the Committee on Animal Use and Care of
Southeast University. The dynamic inhalation exposure
chambers were outfitted with an aerosol generator
(Beijing HuiRongHe Technology Co., Ltd, China). . Mice
were divided into six groups (with six male and six
female mice in each group): control, mice treated with
100 mg/kg ALCAR, mice treated with low and high
doses of Al2O3 NPs, mice treated with a low dose of
Al2O3 NPs + 100 mg/kg ALCAR, and mice treated with
a high dose of Al2O3 NPs + 100 mg/kg ALCAR. Mice
were housed six per polycarbonate cage on corncob bed-
ding with ad libitum access to food and water. Exposure
was carried out in three whole-body inhalation cham-
bers; two chambers received low or high dose of Al2O3
NPs and the control chamber received HEPA-filtered
clean air at the same flow rates as the experimental
groups. Six males and six females were exposed in each
chamber for 8 h per day for 7 consecutive days. Light cy-
cles were set on a 12/12 h light/dark cycle. Al2O3 NPs in
the chamber were generated by the aerosol generator
and mean concentrations of Al2O3 NPs were 2 mg/m
3
and 10 mg/m3 for low and high dose treatments, re-
spectively. The concentration of Al2O3 NPs were moni-
tored by an extensive air quality monitoring equipment
(CEL-712 Microdust Pro, CASELLA, UK). 100 mg/kg
ALCAR was orally administrated by gavage. The
temperature, air flow rate and relative humidity in the
chambers was set to 22.5 °C, 40 L/min, and 50 ± 10 %.
Histopathological analysis of mice lung tissue
Mice were euthanized under ether anesthesia 1 h after
the end of dynamic Al2O3 NP exposure on the 7
th day.
All the mice were decaptitated on an iced table. Lung
tissue was divied for three parts. One piece was immedi-
ately prepared for capasse activity, ATP level, ROS and
MDA analysis. The second piece was stored in liquid ni-
trogen, while another piece was preserved in 4 % para-
formaldehyde (PFA) for 24 h at 4 °C, embedded in
paraffin, serially sectioned (5 μm) and mounted on silane-
covered slides. After dewaxing, the sections selected from
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each mouse were stained with hematoxylin and eosin
(HE) and evaluated under a light microscope (400×) to
examine the histology of the lung tissues. The severity of
pathological lesions was scored according to Szapiel’s
method (Additional file 1: Table S1) [49].
Apoptotic cells in lung tissues were evaluated through
Terminal-deoxynucleoitidyl transferase mediated nick
end labeling (TUNEL) staining by a Roche In Situ Cell
Death Detection Kit (Roche, U.S.) according to the sug-
gested protocols. The proportion of TUNEL-positive
cells of bronchial epithelia were estimated by an experi-
enced histologists blinded to treatment conditions. Five
non-overlapping bronchial tubes of each section were
counted in high-power fields (HPFS, ×400 magnifica-
tion) and analyzed. The bronchial tubes had a maximum
of positive cells were selected.
Cell viability
Cellular viability was evaluated by a CCK-8 proliferation
assay using a Cell Counting Kit-8 (Nanjing Jiancheng
Bioengineering Institute, China). HBE cells were plated
at a density of 1 × 104 per well in a 96-well plate and
treated with 0, 12.5, 25, 50, 100, 250, 500, 1 000 μg/ml
(corresponding to 0, 3.91, 7.81, 15.62, 31.25, 78.13,
156.25, 312.5 μg/cm2) Al2O3 NPs with eight biological
replicates for each concentration. 10 μL of CCK-8 was
added to each well, cells were incubated for 4 h at 37 °C,
and the absorbance was determined at 450 nm. Cell via-
bility affected by Al2O3 NPs were monitored every 24 h
for up to 7 days.
Cell apoptosis analysis
Apoptosis was assessed by flow cytometry using a
KeyGEN Annexin V-FITC Apoptosis Detection Kit (Key-
GEN BioTECH, China) according to the manufacturer’s
instructions. Briefly, after exposure to 100 or 500 μg/ml
Al2O3 NPs for 12 or 24 h, HBE cells were harvested and
incubated with 5 μl FITC-conjugated annexin V and 5 μl
PI for 15 min at room temperature in the dark. The sam-
ples were analyzed by a FACS Calibur Flow Cytometer
(BD Biosciences, USA).
Assessment of caspase-3, caspase-8, and caspase-9
activities
Caspase activity assay kits (Beyotime Institute of Bio-
technology, China) were used to evaluate caspase-3, 8,
and 9 activities in HBE cell lysates and lung tissues ac-
cording to the manufacturer’s instructions. Briefly,
0.05 g lung tissues were homogenized with 500 μl lysis
buffer on ice. cells were lysed with lysis buffer. Protein
content was measured by the Bradford method. Ac-DEVD-
pNA, Ac-IETD-pNA, Ac-LEHD-pNA were substrate pep-
tides of caspase-3, 8, and 9 respectively, and incubated with
Al2O3 NPs-treated cell or lung tissue lysate for 2 h at 37 °C.
The release of p-nitroanilide (pNA) from substrates was
measured at 405 nm by a microplate reader (Molecular
Devices, U.S.).
Mitochondria functions analysis
ATP levels were measured using a luciferase ATP assay
kit (Beyotime, China). Briefly, 200 μL of lysis buffer was
added to cells treated or untreated with Al2O3 NPs. Cells
were collected and centrifuged at 12 000 rpm for 5 min
at 4 °C. 0.05 g lung tissue were homogenized with 250 μl
lysis buffer, then centrifuged at 12,000 rpm for 5 min at
4 °C. The luminescence of the supernatant was assayed by
a luminometer (Berthold Detection System, Pforzheim,
Germany). The cationic dye JC-1 was used to detect the
mitochondrial membrane potential, and HBE cells ex-
posed to Al2O3 NPs 12 or 24 h were evaluated under a
fluorescence microscope (Olympus, Japan) to examine
green and red fluorescence.
To determine the release of cytochrome c, mito-
chondrial and cytosolic proteins were isolated by a
Mitochondria/Cytosol Fractionation Kit (Beyotime,
China) according to the manufacturer’s instructions.
The protein concentrations in cytosol and mitochon-
dria samples were measured using the Bradford
method. The levels of cytochrome c were estimated
according to the ELISA kit procedures (R&D Systems,
U.S.). For all of these mitochondrial-involved assays,
CCCP was employed as positive control.
Measurements of reactive oxygen species (ROS),
superoxide (O2
.-), hydrogen peroxide (H2O2) and
malondialdehyde (MDA) levels
After 12 or 24 h exposure to 100 or 500 μg/ml Al2O3
NPs, HBE cells were washed with PBS. 0.05 g fresh mice
lung were homogenized by with 1 mL PBS, and centri-
fuged at 1,600 g for 10 min at 4 °C. Then DCFH-DA
probe was added (Beyotime, China) with a final concen-
tration of 10 μmol/L to determine the content of intra-
cellular ROS. The fluorescence intensity was measured
after 30 min incubation at 37 °C under a fluorescence
microscope (Olympus, Japan), and quantified by a fluor-
escence spectrophotometer. O2
.- levels in the cell lysate
were determined by WST-1 assay. The concentration of
formazan, the reduced product of NBT was measured at
560 nm. H2O2 concentration in cells was determined by
optical density (OD) at 560 nm, indicative of H2O2 oxi-
dization of trivalent ferric and xylenol orange. The con-
centrations of MDA in cellular and lung tissue lysate
were assessed by measuring thiobarbituric-acid (TBA)
reacting substances at 532 nm. The level of MDA was
expressed as nmol MDA per milligram protein. Protein
content was measured by Bradford method. For all of
these oxidative stress and lipid peroxidation related
assays, CCCP was employed as positive control.
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ALCAR rescue to Al2O3 NPs induced mitochondrial
dysfunction
Cell viability of HBE cells treated with PBS, 0.1,
0.3 mg/ml ALCAR, 500 μg/ml Al2O3 NPs, 0.1 mg/ml
ALCAR+ 500 μg/ml Al2O3 NPs, or 0.3 mg/ml ALCAR +
500 μg/ml Al2O3 NPs was assessed to determine an
appropriate therapeutic dose of ALCAR.
To validate the protective effects of ALCAR against
mitochondrial dysfunction, HBE cells were treated with
PBS, 100, 500 μg/ml Al2O3 NPs, 0.3 mg/ml ALCAR,
0.3 mg/ml ALCAR+ 100 μg/ml Al2O3 NPs or 0.3 mg/ml
ALCAR+ 500 μg/ml Al2O3 NPs for 24 h. Then mito-
chondrial membrane potential, ROS, ATP, MDA levels,
caspase-3, 8, and 9 activities, and O2
.- levels in HBE cells
were determined.
RNA isolation and quantitative real-time PCR assay
HBE cells were seeded in 6-well plates at a density of
about 1 × 106 cells per well, and exposed to 50, 100, 250,
or 500 μg/ml Al2O3 NPs or control medium for 24 h,
then cells were trypsinized and collected. The mice lung
tissue stored in liquid nitrogen were homogenized in
ice-cold 50 mM Tris–HCl buffer (pH 7.55).
Total RNA of HBE cells and lung tissues were ex-
tracted using a GenEluteTM Mammalian Total RNA
Miniprep Kit (Sigma, U.S.) according to the manufac-
turer’s protocol, and the concentration of total RNA was
determined by measuring the absorbance at 260 nm
using a Nanodrop 2000c spectrophotometer (Thermo
Scientific, U.S.). cDNA synthesis for coding genes was
performed with 1ug of total RNA according to the man-
ufacturer’s instruction (Takara, Japan).
The mRNA levels for modulated genes were determined
by reverse transcription of total RNA followed by quanti-
tative real-time PCR analysis (qRT-PCR) on a Quant Stu-
dio 6 Flex system (Applied Biosystems, Life Technologies,
U.S.) using SYBR PCR Master Mix reagent kits (Takara,
Japan) following the manufacturer’s protocol. Primers
were designed for the modulated genes screened by RNA
microarray, and are provided in Additional file 1: Table S2
and S3. All experiments were performed in triplicate. The
mRNA levels provided were normalized to cyclophilin A.
Data analysis
Values of cell viability, apoptosis, and mitochondrial dys-
function assays are expressed as mean ± standard error
of the mean (SE). Statistically significant differences were
determined by one-way ANOVA, followed by Dunnett’s
multiple comparison tests. Kruskal-Wallis test was
used to analyze the ranked data of pulmonary lesion
scores. The method of 2 –ΔΔCt was used to analyze
the results of RT-PCR in all experiments. Statistical
analysis was performed by SPSS12.0 and the signifi-
cance was set at P < 0.05.
Additional file
Additional file 1: Supplementary documents Figure S1-3 with figure
legend and Tables S1-3. (PDF 793 kb)
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